Telcare develops machine-2-machine cellular technology that wirelessly connects patients and physicians to cure chronic illnesses.
Telcare wirelessly bridges the last mile between patients and physicians for the care of chronic illness using machine-2-machine cellular technology. The Company's first product in development is the TelCheck glucose meter, which automatically relays home glucose testing data to the physician or care manager and displays immediate clinical feedback and coaching on the screen of the meter. Telcare recently won the people's choice award at the 2009 CTIA show in San Diego, CA
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 21, 2014 | Series C | $32.50M | 2 | Norwest Venture Partners | — | Detail |
Aug 22, 2012 | Series B | $25.50M | 1 | Sequoia Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Norwest Venture Partners | Yes | Series C |
Sequoia Capital | — | Series C |